Myeloma
Results
Phase 3
This trial looked at different ways to have carfilzomib for people with myeloma that had come back or treatment had stopped working.
The trial was open for people to join between 2015 and 2016. The research team published the results in 2018.
Recruitment start: 1 September 2015
Recruitment end: 1 August 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Catherine Williams
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Onyx Pharma
Last reviewed: 6 June 2024
CRUK internal database number: 13691